A detailed history of Franklin Resources Inc transactions in Staar Surgical CO stock. As of the latest transaction made, Franklin Resources Inc holds 31,844 shares of STAA stock, worth $795,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,844
Previous 31,844 -0.0%
Holding current value
$795,144
Previous $1.18 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$29.97 - $47.42 $424,435 - $671,562
14,162 Added 80.09%
31,844 $1.18 Million
Q2 2024

Aug 14, 2024

BUY
$38.07 - $52.25 $78,271 - $107,426
2,056 Added 13.16%
17,682 $841,000
Q1 2024

May 13, 2024

SELL
$27.67 - $39.61 $16,878 - $24,162
-610 Reduced 3.76%
15,626 $598,000
Q4 2023

Feb 09, 2024

SELL
$30.6 - $43.78 $24,786 - $35,461
-810 Reduced 4.75%
16,236 $506,000
Q3 2023

Nov 13, 2023

BUY
$39.39 - $58.12 $357,424 - $527,380
9,074 Added 113.82%
17,046 $684,000
Q2 2023

Aug 11, 2023

BUY
$50.45 - $72.82 $402,187 - $580,521
7,972 New
7,972 $419,000
Q4 2022

Feb 10, 2023

SELL
$46.82 - $76.2 $12,266 - $19,964
-262 Reduced 4.09%
6,142 $298,000
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $129,882 - $205,418
1,841 Added 40.35%
6,404 $452,000
Q2 2022

Aug 11, 2022

SELL
$50.24 - $80.48 $150,368 - $240,876
-2,993 Reduced 39.61%
4,563 $324,000
Q1 2022

May 13, 2022

SELL
$57.98 - $93.5 $22,032 - $35,530
-380 Reduced 4.79%
7,556 $604,000
Q4 2021

Feb 11, 2022

SELL
$88.02 - $127.79 $44,890 - $65,172
-510 Reduced 6.04%
7,936 $725,000
Q3 2021

Nov 12, 2021

BUY
$122.75 - $162.68 $800,330 - $1.06 Million
6,520 Added 338.53%
8,446 $1.09 Million
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $203,693 - $298,452
1,926 New
1,926 $293,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.2B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.